We are live on ! Find out more
NNVC icon

NanoViricides

29 hedge funds and large institutions have $1.38M invested in NanoViricides in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more capital invested

Capital invested by funds: $1.24M → $1.38M (+$149K)

0.19% less ownership

Funds ownership: 10.33%10.14% (-0.19%)

9% less funds holding

Funds holding: 3229 (-3)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

Holders
29
Holders Change
-3
Holders Change %
-9.38%
% of All Funds
0.42%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
3
Reduced
6
Closed
6
Calls
$28K
Puts
Net Calls
+$28K
Net Calls Change
-$11K

NNVC Hedge Fund Activity: Q1 2024 in Review

29 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q1 2024, worth a combined $1.38M — up 12% from $1.24M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of NNVC and 3 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 3 added.

The largest buyer was Renaissance Technologies, adding an estimated $6.88K. The largest seller was Virtu Financial, exiting entirely with an estimated $17K sold.

  • 29 institutional investors held NanoViricides (NNVC) as of Q1 2024, down from 32 in Q4 2023.
  • Funds reported $1.38M of NanoViricides stock for Q1 2024, up 12% quarter-over-quarter.
  • 3 funds opened new NanoViricides positions in Q1 2024 and 6 closed out, a net change of -3 holders.
  • The largest NanoViricides buyer in Q1 2024 was Renaissance Technologies, an estimated $6.88K added.
  • The largest NanoViricides seller in Q1 2024 was Virtu Financial, an estimated $17K sold.

Based on aggregated 13F filings for Q1 2024.